CP17736969425485502 — Ravulizumab-cwvz 1100 Mg/11ml IV Soln
$20,896
All-payer median here
$23,882
Cash / self-pay here
3
payer/plan-name variants
Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.